chr16-1175628-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_021098.3(CACNA1H):c.300-19344A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.159 in 152,082 control chromosomes in the GnomAD database, including 2,865 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.16 ( 2865 hom., cov: 33)
Consequence
CACNA1H
NM_021098.3 intron
NM_021098.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.91
Publications
8 publications found
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.649 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11 | c.300-19344A>G | intron_variant | Intron 2 of 34 | 1 | NM_021098.3 | ENSP00000334198.7 | |||
| CACNA1H | ENST00000569107.6 | c.300-19344A>G | intron_variant | Intron 2 of 33 | 1 | ENSP00000454990.2 | ||||
| CACNA1H | ENST00000711493.1 | c.300-19344A>G | intron_variant | Intron 2 of 33 | ENSP00000518778.1 | |||||
| CACNA1H | ENST00000565831.7 | c.300-19344A>G | intron_variant | Intron 2 of 33 | 1 | ENSP00000455840.1 | ||||
| CACNA1H | ENST00000711450.1 | c.300-19344A>G | intron_variant | Intron 2 of 34 | ENSP00000518762.1 | |||||
| CACNA1H | ENST00000564231.6 | c.300-19344A>G | intron_variant | Intron 2 of 34 | 1 | ENSP00000457555.2 | ||||
| CACNA1H | ENST00000638323.1 | c.300-19344A>G | intron_variant | Intron 2 of 34 | 5 | ENSP00000492267.1 | ||||
| CACNA1H | ENST00000562079.6 | c.300-19344A>G | intron_variant | Intron 2 of 33 | 1 | ENSP00000454581.2 | ||||
| CACNA1H | ENST00000711438.1 | c.300-19344A>G | intron_variant | Intron 2 of 33 | ENSP00000518754.1 | |||||
| CACNA1H | ENST00000711482.1 | c.300-19344A>G | intron_variant | Intron 2 of 35 | ENSP00000518771.1 | |||||
| CACNA1H | ENST00000711485.1 | c.300-19344A>G | intron_variant | Intron 2 of 34 | ENSP00000518774.1 | |||||
| CACNA1H | ENST00000711455.1 | c.300-19344A>G | intron_variant | Intron 2 of 35 | ENSP00000518768.1 | |||||
| CACNA1H | ENST00000711483.1 | c.300-19344A>G | intron_variant | Intron 2 of 34 | ENSP00000518772.1 | |||||
| CACNA1H | ENST00000711456.1 | c.300-19344A>G | intron_variant | Intron 2 of 33 | ENSP00000518769.1 | |||||
| CACNA1H | ENST00000621827.2 | n.300-19344A>G | intron_variant | Intron 2 of 36 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3 | n.300-19344A>G | intron_variant | Intron 2 of 33 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1 | n.300-19344A>G | intron_variant | Intron 2 of 34 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1 | n.300-19344A>G | intron_variant | Intron 2 of 34 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1 | n.300-19344A>G | intron_variant | Intron 2 of 33 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1 | n.300-19344A>G | intron_variant | Intron 2 of 35 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1 | n.300-19344A>G | intron_variant | Intron 2 of 34 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1 | n.300-19344A>G | intron_variant | Intron 2 of 35 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1 | n.300-19344A>G | intron_variant | Intron 2 of 35 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1 | n.300-19344A>G | intron_variant | Intron 2 of 35 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1 | n.300-19344A>G | intron_variant | Intron 2 of 34 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1 | n.300-19344A>G | intron_variant | Intron 2 of 36 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1 | n.300-19344A>G | intron_variant | Intron 2 of 35 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1 | n.300-19344A>G | intron_variant | Intron 2 of 34 | ENSP00000518777.1 |
Frequencies
GnomAD3 genomes AF: 0.159 AC: 24151AN: 151962Hom.: 2864 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
24151
AN:
151962
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.159 AC: 24153AN: 152082Hom.: 2865 Cov.: 33 AF XY: 0.169 AC XY: 12549AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
24153
AN:
152082
Hom.:
Cov.:
33
AF XY:
AC XY:
12549
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
4353
AN:
41504
American (AMR)
AF:
AC:
1745
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
235
AN:
3470
East Asian (EAS)
AF:
AC:
3450
AN:
5164
South Asian (SAS)
AF:
AC:
1189
AN:
4822
European-Finnish (FIN)
AF:
AC:
2925
AN:
10566
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9867
AN:
67968
Other (OTH)
AF:
AC:
302
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
961
1921
2882
3842
4803
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
278
556
834
1112
1390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1359
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.